Research ExplorerJournalsCURR CANCER DRUG TAR

CURR CANCER DRUG TAR

Bibliographical data

ISSNs1568-0096

Publications

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL
Nilsson, S., Stein, A., Rolfo, C., Kranich, A., Mann, J., Papadimitriou, K., Theile, S., Amberg, S. & Bokemeyer, C., 27.06.2020, In: CURR CANCER DRUG TAR. 20, 10, p. 811-817 7 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Atanackovic, D., Luetkens, T., Radhakrishnan, S. & Kroger, N., 2017, In: CURR CANCER DRUG TAR. 17, 9, p. 839-845 7 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Clinical experience with antiangiogenic therapy in leukemia.
Wellbrock, J. & Fiedler, W., 2011, In: CURR CANCER DRUG TAR. 11, 9, p. 1053-1068 9.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Implication of heat shock protein 90 (HSP90) in tumor angiogenesis: a molecular target for anti-angiogenic therapy?
Staufer, K. & Stöltzing, O., 2010, In: CURR CANCER DRUG TAR. 10, 8, p. 890-897 8.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Allelic imbalances of the egfr gene as key events in breast cancer progression--the concept of committed progenitor cells.
Agelopoulos, K., Buerger, H. & Brandt, B., 2008, In: CURR CANCER DRUG TAR. 8, 5, p. 431-445 5.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Integrins in cancer treatment
Eble, J. A. & Haier, J., 03.2006, In: CURR CANCER DRUG TAR. 6, 2, p. 89-105 17 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (6)